pcDNA3.1-3xFLAG-V5-ccdB Citations (5)
Originally described in: Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition.Taipale M, Krykbaeva I, Koeva M, Kayatekin C, Westover KD, Karras GI, Lindquist S Cell. 2012 Aug 31;150(5):987-1001. doi: 10.1016/j.cell.2012.06.047. PubMed Journal
Articles Citing pcDNA3.1-3xFLAG-V5-ccdB
Articles |
---|
YAP-Induced Endothelial-Mesenchymal Transition in Oral Submucous Fibrosis. Li J, Yao M, Zhu X, Li Q, He J, Chen L, Wang W, Zhu C, Shen T, Cao R, Fang C. J Dent Res. 2019 Jul;98(8):920-929. doi: 10.1177/0022034519851804. PubMed |
CRISPR-mediated gene targeting of CK1delta/epsilon leads to enhanced understanding of their role in endocytosis via phosphoregulation of GAPVD1. Guillen RX, Beckley JR, Chen JS, Gould KL. Sci Rep. 2020 Apr 22;10(1):6797. doi: 10.1038/s41598-020-63669-2. PubMed |
Translational Read-Through Therapy of RPGR Nonsense Mutations. Vossing C, Owczarek-Lipska M, Nagel-Wolfrum K, Reiff C, Juschke C, Neidhardt J. Int J Mol Sci. 2020 Nov 10;21(22). pii: ijms21228418. doi: 10.3390/ijms21228418. PubMed |
SARS-CoV-2 Nsp14 activates NF-kappaB signaling and induces IL-8 upregulation. Li T, Kenney AD, Liu H, Fiches GN, Zhou D, Biswas A, Que J, Santoso N, Yount JS, Zhu J. bioRxiv. 2021 May 26. doi: 10.1101/2021.05.26.445787. PubMed |
Does a rare mutation in PTPRA contribute to the development of Parkinson's disease in an Australian multi-incident family? Hill MA, Bentley SR, Walker TL, Mellick GD, Wood SA, Sykes AM. PLoS One. 2022 Jul 28;17(7):e0271499. doi: 10.1371/journal.pone.0271499. eCollection 2022. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.